Greater Manchester announces weight loss medication study

A partnership to better understand weight loss medication has been announced at the Government’s International Investment Summit.

(c) Michal Jarmoluk/Pixabay

(c) Michal Jarmoluk/Pixabay

The five-year study between Health Innovation Manchester and US pharmaceutical company Lilly will evaluate the real-world effectiveness of tirzepatide in weight loss, diabetes prevention and prevention of obesity-related complications for adults with obesity.

Mayor of Greater Manchester, Andy Burnham, said: ‘Greater Manchester is world-renowned as a hub for innovation in health and life sciences. The results of the trial announced today could have a far-reaching impact on how we treat obesity globally, and our city-region is ready to make a significant contribution through our outstanding health data assets, R&D expertise, and the strong partnerships between industry, universities and public sector organisations.'

The five-year study will also aim to collect data on healthcare resource utilisation, health-related quality of life and changes in participants' employment status and sick days from work.

Violence against ambulance staff reaches record levels

Violence against ambulance staff reaches record levels

By Liz Wells 24 April 2025

Association of Ambulance Chief Executives (AACE) is calling for further interventions as violent incidents against ambulance staff reach more than 22,500 a y...

Robotic surgery systems approved for NHS use

By Liz Wells 17 April 2025

NICE has approved 11 robotic surgery systems for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic proc...

Government invests in medical research

By Liz Wells 08 April 2025

The Government and the Wellcome Trust will invest up to £600m to transform access to NHS data, by providing a secure single access point to national-scale da...


Popular articles by Lee Peart